Predicting the Potential Individual‐ and Population‐Level Effects of Imperfect Herpes Simplex Virus Type 2 Vaccines

Abstract
Background. The seroprevalence of herpes simplex virus (HSV) type 2 in the United States has increased dramatically since the 1970s. Vaccines are bei

This publication has 0 references indexed in Scilit: